Effects of Nociceptin/Orphanin FQ in the Acquisition of Contextual and Tone Fear Conditioning in Rats

Behavioral Neuroscience

Volumn 122, Issue 1, 2008, Pages 98-106

  Fornari, Raquel V ^a   Soares, Juliana C K ^a   Ferreira, Tatiana L ^a   Moreira, Karin M ^a   Oliveira, Maria G M ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

emotional memory; fear conditioning; hippocampus; N OFQ; opioid

Indexed keywords

NOCICEPTIN;

ANIMAL EXPERIMENT; ARTICLE; AVERSION; FEAR; FREEZING; HIPPOCAMPUS; LEARNING; MALE; MEMORY; MOTIVATION; NONHUMAN; RAT; STATE DEPENDENT LEARNING; TASK PERFORMANCE; TRAINING;

ACOUSTIC STIMULATION; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROSHOCK; FEAR; FREEZING REACTION, CATALEPTIC; INJECTIONS, INTRAVENTRICULAR; MALE; OPIOID PEPTIDES; RATS; RATS, WISTAR; TIME FACTORS;

EID: 40749085126     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7044.122.1.98     Document Type: Article

References (55)

1. Anagnostaras S.G., Maren S., and Fanselow M.S. Temporally graded retrograde amnesia of contextual fear after hippocampal damage in rats: Within-subjects examination. Journal of Neuroscience 19 (1999) 1106-1114
2. Anton B., Fein J., To T., Li X., Silberstein L., and Evans C.J. Immunohistochemical localization of ORL-1 in the central nervous system of the rat. Journal of Comparative Neurology 368 (1996) 229-251
3. Bruins Slot L.A., and Colpaert F.C. Opiate states of memory: Receptor mechanisms. Journal of Neuroscience 19 (1999) 10520-10529
4. Calo' G., Guerrini R., Rizzi A., Salvadori S., and Regoli D. Pharmacology of nociceptin and its receptor: A novel therapeutic target. British Journal of Pharmacology 129 (2000) 1261-1283
5. Castellano C., and McGaugh J.L. Effect of morphine on one-trial inhibitory avoidance in mice: Lack of state-dependency. Psychobiology 17 (1989) 89-92
6. Cavallini S., Marino S., Beani L., Bianchi C., and Siniscalchi A. Nociceptin inhibition of acetylcholine efflux from different brain areas. NeuroReport 14 (2003) 2167-2170
7. Cruz-Morales S.E., Duran-Arevalo M., Diaz Del Guante M.A., Quirarte G., and Prado-Alcala R.A. A threshold for the protective effect of over-reinforced passive avoidance against scopolamine-induced amnesia. Behavioral Neural Biology 57 (1992) 256-259
8. Devine D.P., Taylor L., Reinscheid R.K., Monsma Jr. F.J., Civelli O., and Akil H. Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ. Neurochemical Research 21 (1996) 1387-1396
9. Fanselow M.S. Associative vs. topographical accounts of the immediate shock freezing deficit in rats-Implications for the response selection-rules governing species-specific defensive reactions. Learning and Motivation 17 (1986) 16-39
10. Fanselow M.S. Contextual fear, gestalt memories, and the hippocampus. Behavioural Brain Research 110 (2000) 73-81
11. Fanselow M.S., and Bolles R.C. Naloxone and shock-elicited freezing in the rat. Journal of Comparative and Physiological Psychology 93 (1979) 736-744
12. Fernandez F., Misilmeri M.A., Felger J.C., and Devine D.P. Nociceptin/orphanin FQ increases anxiety-related behavior and circulating levels of corticosterone during neophobic tests of anxiety. Neuropsychopharmacology 29 (2004) 59-71
13. Ferreira T.L., Moreira K.M., Ikeda D.C., Bueno O.F., and Oliveira M.G. Effects of dorsal striatum lesions in tone fear conditioning and contextual fear conditioning. Brain Research 987 (2003) 17-24
14. Fornari R.V., Moreira K.M., and Oliveira M.G.M. Effects of the selective M1 muscarinic receptor antagonist dicyclomine on emotional memory. Learning & Memory 7 (2000) 287-292
15. Gavioli E.C., and Calo' G. Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands. Naunyn Schmiedebergs Archives of Pharmacology 372 (2006) 319-330
16. Gavioli E.C., Rae G.A., Calo' G., Guerrini R., and De Lima T.C. Central injections of nocistatin or its C-terminal hexapeptide exert anxiogenic-like effect on behaviour of mice in the plus-maze test. British Journal of Pharmacology 136 (2002) 764-772
17. Griebel G., Perrault G., and Sanger D.J. Orphanin FQ, a novel neuropeptide with anti-stress-like activity. Brain Research 836 (1999) 221-224
18. Higgins G.A., Kew J.N., Richards J.G., Takeshima H., Jenck F., Adam G., et al. A combined pharmacological and genetic approach to investigate the role of orphanin FQ in learning and memory. European Journal of Neuroscience 15 (2002) 911-922
19. Hiramatsu M., and Inoue K. Effects of nocistatin on nociceptin-induced impairment of learning and memory in mice. European Journal of Pharmacology 367 (1999) 151-155
20. Hiramatsu M., and Inoue K. Nociceptin/orphanin FQ and nocistatin on learning and memory impairment induced by scopolamine in mice. British Journal of Pharmacology 127 (1999) 655-660
21. Hirata Y., Cezari M.H.S., Nakaie C.R., Boschov P., Ito A.S., Juliano M.A., and Juliano I. Internally quenched fluorogenic proteases: Solid-phase synthesis and fluorescence spectroscopy of peptides containing ortho-aminobenzyl-dinitrophenyl groups as donor-acceptor pairs. Letters in Peptide Science 1 (1995) 299-308
22. Izquierdo I. Effect of beta-endorphin and naloxone on acquisition, memory, and retrieval of shuttle avoidance and habituation learning in rats. Psychopharmacology 69 (1980) 111-115
23. Jenck F., Moreau J.L., Martin J.R., Kilpatrick G.J., Reinscheid R.K., Monsma Jr. F.J., et al. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proceedings of the National Academy of Science of the United States of America 94 (1997) 14854-14858
24. Khavandgar S., Homayoun H., Torkaman-Boutorabi A., and Zarrindast M.R. The effects of adenosine receptor agonists and antagonists on morphine state-dependent memory of passive avoidance. Neurobiology of Learning and Memory 78 (2001) 390-405
25. Kim J.J., and Fanselow M.S. Modality-specific retrograde amnesia of fear. Science 256 (1992, May 1) 675-677
26. Kim J.J., Fanselow M.S., DeCola J.P., and Landeira-Fernandez J. Selective impairment of long-term but not short-term conditional fear by the N-methyl-D-aspartate antagonist APV. Behavioral Neuroscience 106 (1992) 591-596
27. Liu E.H., Lee T.L., Nishiuchi Y., Kimura T., and Tachibana S. Nocistatin and its derivatives antagonize the impairment of short-term acquisition induced by nociceptin. Neuroscience Letters 416 (2007) 155-159
28. Mamiya T., Noda Y., Nishi M., Takeshima H., and Nabeshima T. Enhancement of spatial attention in nociceptin/orphanin FQ receptor-knockout mice. Brain Research 783 (1998) 236-240
29. Mamiya T., Noda Y., Nishi M., Takeshima H., and Nabeshima T. Nociceptin system plays a role in the memory retention: Involvement of naloxone benzoylhydrazone binding sites. NeuroReport 26 (1999) 1171-1175
30. Mamiya T., Yamada K., Miyamoto Y., Konig N., Watanabe Y., Noda Y., and Nabeshima T. Neuronal mechanism of nociceptin-induced modulation of learning and memory: Involvement of N-methyl-D-aspartate receptors. Molecular Psychiatry 8 (2003) 752-765
31. Manabe T., Noda Y., Mamiya T., Katagiri H., Houtani T., Nishi M., et al. Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature 394 (1998, August 6) 577-581
32. Meis S. Nociceptin/orphanin FQ: Actions within the brain. Neuroscientist 9 (2003) 158-168
33. Meunier J.C. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. European Journal of Pharmacology 340 (1997) 1-15
34. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377 (1995, October 12) 532-535
35. Mogil J.S., and Pasternak G.W. The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacology Reviews 53 (2001) 381-415
36. Mollereau C., and Mouledous L. Tissue distribution of the opioid receptor-like (ORL1) receptor. Peptides 21 (2000) 907-917
37. Neal Jr. C.R., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., Akil H., and Watson Jr. S.J. Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: Comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding. Journal of Comparative Neurology 412 (1999) 563-605
38. Neal Jr. C.R., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., and Watson Jr. S.J. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. Journal of Comparative Neurology 406 (1999) 503-547
39. Noda Y., Mamiya T., Manabe T., Nishi M., Takeshima H., and Nabeshima T. Role of nociceptin systems in learning and memory. Peptides 21 (2000) 1063-1069
40. Overton D.A. Dissociated learning in drugs states (state dependent learning). In: Efron D.H., Cole J.O., Levine J., and Wittenborn J.R. (Eds). Psychopharmacology: A review of progress 1957-1967 (1968), Public Health Service, Washington, DC 918-930
41. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 3rd ed. (1997), Academic Press, San Diego, CA
42. Phillips R.G., and LeDoux J.E. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behavioral Neuroscience 106 (1992) 274-285
43. Redrobe J.P., Calo' G., Guerrini R., Regoli D., and Quirion R. [Nphe(1)]-Nociceptin (1-13)-NH(2), a nociceptin receptor antagonist, reverses nociceptin-induced spatial memory impairments in the Morris water maze task in rats. British Journal of Pharmacology 131 (2000) 1379-1384
44. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., et al. Orphanin FQ: A neuropeptide that activates an opioidlike G protein-coupled receptor. Science 270 (1995, November 3) 792-794
45. Roozendaal B., Lengvilas R., McGaugh J.L., Civelli O., and Reinscheid R.K. Orphanin FQ/nociceptin interacts with the basolateral amygdala noradrenergic system in memory consolidation. Learning & Memory 14 (2007) 29-35
46. Rudy J.W., and Morledge P. Ontogeny of contextual fear conditioning in rats: Implications for consolidation, infantile amnesia, and hippocampal system function. Behavioral Neuroscience 108 (1994) 227-234
47. Sandin J., Georgieva J., Schott P.A., Ogren S.O., and Terenius L. Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats. European Journal of Neuroscience 9 (1997) 194-197
48. Sandin J., Ogren S.O., and Terenius L. Nociceptin/orphanin FQ modulates spatial learning via ORL-1 receptors in the dorsal hippocampus of the rat. Brain Research 997 (2004) 222-233
49. Schenberg E.E., Soares J.C., and Oliveira M.G.M. Effects of pre- or post-training entorhinal cortex AP5 injection on fear conditioning. Physiology & Behavior 86 (2005) 508-515
50. Solana-Figueroa R., Salado-Castillo R., Quirarte G.L., Galindo L.E., and Prado-Alcala R.A. Enhanced inhibitory avoidance training protects against the amnesic effect of p-chloroamphetamine. Life Sciences 71 (2002) 391-399
51. Sullivan G.M., Apergis J., Bush D.E., Johnson L.R., Hou M., and Ledoux J.E. Lesions in the bed nucleus of the stria terminalis disrupt corticosterone and freezing responses elicited by a contextual but not by a specific cue-conditioned fear stimulus. Neuroscience 128 (2004) 7-14
52. Werthwein S., Bauer U., Nakazi M., Kathmann M., and Schlicker E. Further characterization of the ORL1 receptor-mediated inhibition of noradrenaline release in the mouse brain in vitro. British Journal of Pharmacology 127 (1999) 300-308
53. Yu T.P., Fein J., Phan T., Evans C.J., and Xie C.W. Orphanin FQ inhibits synaptic transmission and long-term potentiation in rat hippocampus. Hippocampus 7 (1997) 88-94
54. Yu T.P., and Xie C.W. Orphanin FQ/nociceptin inhibits synaptic transmission and long-term potentiation in rat dentate gyrus through postsynaptic mechanisms. Journal of Neurophysiology 80 (1998) 1277-1284
55. Zarrindast M.R., and Rezayof A. Morphine state-dependent learning: Sensitization and interactions with dopamine receptors. European Journal of Pharmacology 497 (2004) 197-204